Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease

American Journal of Nephrology

Volumn 29, Issue 5, 2009, Pages 420-425

  Joki, Nobuhiko ^a   Tanaka, Yuri ^a   Ishikawa, Hiroyasu ^a   Takahashi, Yasunori ^a   Iwakura, Yoshitsugu ^a   Masuda, Haruka ^a   Inishi, Yoji ^a   Hase, Hiroki ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

C reactive protein; Coronary artery disease; Initiation of hemodialysis; Major adverse cardiac event; Screening

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ADVERSE OUTCOME; ANGIOCARDIOGRAPHY; AORTA DISSECTION; ARTERY DISEASE; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESCREENING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SUDDEN DEATH; SURVIVAL; UNSTABLE ANGINA PECTORIS;

AGED; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 55449094090     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172617     Document Type: Article

References (15)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119.
2. Joki N, Hase H, Nakamura R, Yamaguchi T: Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997;12:718-723.
3. Ohtake T, Kobayashi S, Moriya H, et al: High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005;16:1141-1148.
4. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005;45:S1-S153.
5. Tanaka Y, Joki N, Hase H: History of acute coronary events during the predialysis phase of chronic kidney disease is a strong risk factor for major adverse cardiac events in patients initiating haemodialysis. Nephrol Dial Transplant 2007;22:2917-2923.
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
7. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(suppl 1):S5-S20
8. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
9. Ridker PM, Cushman M, Stampfer M J, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979.
10. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
11. Zoccali C, Mallamaci F, Tripepi G: Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrol Dial Transplant 2004; 19(suppl 5):V67-V72.
12. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164:659-663.
13. Gowdak LH, de Paula FJ, Cesar LA, et al: Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates. Nephrol Dial Transplant 2007;22:1456-1461.
14. Cao JJ, Arnold AM, Manolio TA, et al: Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007; 116:32-38.
15. Stenvinkel P, Wanner C, Metzger T, et al: Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 2002;62:1791-1798.